| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.25B | — | -0.6% |
| Cost of Revenue | $838.0M | — | +1.1% |
| R&D Expense | $18.0M | — | +5.9% |
| SG&A Expense | $200.0M | — | -1.0% |
| Operating Income | $146.0M | — | -17.0% |
| Pre-tax Income | $105.0M | — | -18.6% |
| Income Tax | $14.0M | — | -53.3% |
| Net Income | $90.0M | — | -9.1% |
| EPS (Basic) | $0.42 | — | -6.7% |
| EPS (Diluted) | $0.42 | — | -6.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $608.0M | -7.5% | +5.7% |
| Accounts Receivable | $981.0M | -3.3% | -5.7% |
| Inventory | $770.0M | +1.9% | -2.2% |
| Current Assets | $2.83B | +0.4% | +0.2% |
| Total Assets | $7.56B | -0.5% | +2.0% |
| Current Liabilities | $1.35B | -1.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $68.0M | — | +161.5% |
| Capital Expenditures | $50.0M | — | +16.3% |
| Investing Cash Flow | -$53.0M | — | -20.5% |
| Financing Cash Flow | -$61.0M | — | -662.5% |
| Free Cash Flow | $18.0M | — | +205.9% |
| +1.4% |
| Long-term Debt | $3.13B | -1.6% | -8.0% |
| Total Liabilities | $5.09B | -2.2% | -3.7% |
| Stockholders' Equity | $2.42B | +3.2% | +16.6% |